Last Price
4.55
Today's Change
-0.08 (1.72%)
Day's Change
4.51 - 4.66
Trading Volume
235,639
Market Cap
156 Million
Shares Outstanding
34 Million
Avg Volume
2,410,313
Avg Price (50 Days)
4.29
Avg Price (200 Days)
2.86
PE Ratio
-1.72
EPS
-2.64
Earnings Announcement
11-Mar-2025
Previous Close
4.63
Open
4.56
Day's Range
4.51 - 4.66
Year Range
1.595 - 10.48
Trading Volume
235,639
1 Day Change
-1.73%
5 Day Change
-16.82%
1 Month Change
-11.82%
3 Month Change
138.22%
6 Month Change
101.33%
Ytd Change
-18.46%
1 Year Change
112.62%
3 Year Change
-25.65%
5 Year Change
-83.94%
10 Year Change
-99.01%
Max Change
-98.87%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.